Geert Cauwenbergh
2021
In 2021, Geert Cauwenbergh earned a total compensation of $58.3K as Former interim Principal Executive and Financial Officer at RXi Pharmaceuticals.
Compensation breakdown
| Salary | $27,500 |
|---|---|
| Stock Awards | $30,800 |
| Total | $58,300 |
Cauwenbergh received $30.8K in stock awards, accounting for 53% of the total pay in 2021.
Cauwenbergh also received $27.5K in salary.
Rankings
In 2021, Geert Cauwenbergh's compensation ranked 12,299th out of 12,415 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,299 out of 12,415 | 1st |
Division Manufacturing | 5,456 out of 5,508 | 1st |
Major group Chemicals And Allied Products | 2,364 out of 2,378 | 1st |
Industry group Drugs | 2,087 out of 2,099 | 1st |
Industry Pharmaceutical Preparations | 1,541 out of 1,549 | 1st |
Source: SEC filing on June 9, 2023.
Cauwenbergh's colleagues
We found two more compensation records of executives who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2021.